Physician profile
Marc Moreau
NPI 1487628293
$12,371.30
in general payments reported to CMS, 2019-2025
34 companies · $5,061 in 2025
The $5,061 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $329 · 2021: $644 · 2022: $1,114 · 2023: $860 · 2024: $3,558 · 2025: $5,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,593 · Travel and Lodging: $2,955 · Long Term Medical Supply Or Device Loan: $1,880 · Education: $51.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,593.48 |
| Travel and Lodging | $2,955.06 |
| Long Term Medical Supply Or Device Loan | $1,880.00 |
| Education | $51.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,946.75 | 2023-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Medtronic, INC. | $1,932.80 | 2021-2025 | Turbohawk, Symplicity G3, In.Pact Admiral |
| Abiomed | $1,484.71 | 2019-2025 | Impella |
| Penumbra, INC. | $1,105.79 | 2024 | Ruby Coil |
| Amgen INC. | $990.84 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $545.74 | 2021-2025 | Coroflow, Jot Dx, Xience Skypoint |
| Novartis Pharmaceuticals Corporation | $538.65 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $512.30 | 2019-2025 | Farxiga, Lokelma |
| Merck Sharp & Dohme LLC | $446.35 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $419.50 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $337.88 | 2022-2025 | General - Balloon Catheters |
| Shockwave Medical, INC | $294.95 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $238.84 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.60 | 2023-2025 | Jardiance |
| Biotronik INC. | $182.51 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $150.00 | 2020 | |
| Eisai INC. | $130.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $118.07 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $116.69 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.43 | 2022-2025 | |
| Philips North America LLC | $106.35 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $75.16 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.13 | 2020-2025 | Lifevest |
| Novo Nordisk INC | $56.24 | 2023-2025 | Wegovy, Ozempic |
| Actelion Pharmaceuticals US, INC. | $50.90 | 2023-2024 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $45.13 | 2019 | |
| Cardinal Health 200 LLC | $34.07 | 2019 | |
| Acist Medical Systems, INC. | $22.48 | 2022 | |
| Esperion Therapeutics, INC. | $21.86 | 2024 | Nexletol |
| Scpharmaceuticals INC. | $19.81 | 2024 | |
| Daiichi Sankyo INC. | $18.14 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.74 | 2019 | |
| Gilead Sciences, INC. | $17.08 | 2019 | |
| Medtronic Vascular, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Moreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.